Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Weight Loss Clinic Bangkok — Doctor-Led GLP-1
Recommended by Doctor
Medical Weight Loss Hub

Weight Loss Clinic Bangkok — Doctor-Led GLP-1

Feel Better. Live Longer. · Healthi Life, Ekkamai 10 Bangkok

Doctor-led medical weight loss at Healthi Life Ekkamai. Three physician-supervised GLP-1 options — Mounjaro, Wegovy and Retatrutide — selected on the basis of your medical history, contraindications and baseline biomarkers. Prescription only.

Starting fromFrom ฿10,000

Per vial — full program confirmed at physician consultation

Book ConsultationWhatsAppCall +66 91 999 1744
Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

What You Get

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Personalized GLP-1 selection and titration plan
Why Choose This Treatment

Why a Doctor-Led GLP-1 Program

Doctor-Led, Not Cosmetic

Programs initiated by a licensed physician after full medical intake and contraindication screening.

Three GLP-1 Options

Mounjaro (dual GIP/GLP-1), Wegovy (GLP-1), Retatrutide (investigational triple agonist) — matched to your profile.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

MTC, MEN-2, pancreatitis and pregnancy screening before any prescription.

Injection Training

Weekly subcutaneous self-injection taught in clinic, with adherence support.

Longevity Integration

Integrated with hormone, metabolic and biomarker programs for long-term outcomes.

Is This Right For You?

Ideal For

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review
  • Expats and international visitors — start in-clinic, continue by telemedicine

Not Recommended For

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
Your Journey

Our 4-Step Medical Weight Loss Process

1

Physician Consultation

Full medical history, medication review and goal-setting with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before any prescription.

3

Molecule Selection

The physician selects Mounjaro, Wegovy or Retatrutide based on your profile and contraindications.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

Medical Excellence

Why Trust Healthi Life

Physician-led protocols, international certifications, and a commitment to guest safety in Bangkok.

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards

Mounjaro vs Wegovy vs Retatrutide

A factual comparison of mechanism, status and administration. Individual response varies; all three require physician supervision.

FeatureMounjaroWegovyRetatrutide
MoleculeTirzepatideSemaglutideRetatrutide
Receptor targetsGIP + GLP-1 (dual)GLP-1 onlyGIP + GLP-1 + glucagon (triple)
Injection frequencyOnce weeklyOnce weeklyOnce weekly
Regulatory statusFDA approved (T2D, weight)FDA approved (weight)Investigational (Phase III)
ManufacturerEli LillyNovo NordiskEli Lilly
At Healthi LifeFrom ฿12,000 / vialOn requestFrom ฿10,000 / vial

⚕️ Prescription-only medicines. Initiated and supervised by a licensed physician at Healthi Life Ekkamai.

Packages

Choose Your Program

Wegovy Program

On request

  • Semaglutide 2.4 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
Select Package
RECOMMENDED

Mounjaro Program

From ฿12,000

  • Tirzepatide 2.5–10 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
Select Package

Retatrutide Program

From ฿10,000

  • Investigational triple agonist
  • Research-use informed consent
  • Extended biomarker panel
  • Monthly follow-up
Select Package
FAQ

Frequently Asked Questions

A physician-supervised program combining medical intake, contraindication screening, baseline biomarkers, a prescribed GLP-1 medication (Mounjaro, Wegovy or Retatrutide) and monthly follow-up. It is doctor-led, not a cosmetic or over-the-counter service.

There is no single best option. Mounjaro is a dual GIP/GLP-1 agonist approved for type 2 diabetes and weight management. Wegovy is a GLP-1 agonist approved for weight management. Retatrutide is investigational. The physician selects based on indications, contraindications and biomarker profile.

No. Retatrutide is an investigational triple agonist (Phase III) and is not authorised in the European Union, so it is neither sold nor prescribed in European pharmacies. At Healthi Life Ekkamai in Bangkok it is administered only under physician supervision in a research framework, with informed consent, from ฿10,000 per vial. Products sold online without a prescription carry no quality guarantee and are never recommended.

Mounjaro and Wegovy are prescription medicines and must be initiated by a licensed physician. Retatrutide is investigational and is offered only under physician supervision in a research framework. They cannot be sold over the counter.

Most guests follow a 3 to 12 month physician-supervised program, with monthly follow-up. Duration is individualized based on clinical goals, tolerability, biomarker trends and the broader longevity plan.

The most reported effects are nausea, diarrhea, decreased appetite, vomiting and constipation, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease. Every program includes monthly side-effect review.

Yes. HbA1c, lipid panel, hepatic and renal function are established before the first dose. For Retatrutide, an extended panel is added. Follow-up labs are reviewed at every monthly visit.

Yes. GLP-1 medicines such as Mounjaro and Wegovy are legal in Thailand when prescribed by a licensed physician, with no residency or long-term visa required. Expats and short-stay visitors are equally welcome at Healthi Life Ekkamai — your program starts with an in-clinic physician consultation and baseline labs, and monthly follow-up can continue by telemedicine once you have travelled home, so dosing stays monitored.

GLP-1 medicines are temperature-sensitive and must be kept cold. After in-clinic injection training, your physician advises on safe cold-chain transport, self-injection and titration for the weeks between visits. Retatrutide, being investigational, is administered within a supervised research framework and is not dispensed for unsupervised long-term travel.

What the Research Shows

Medical weight management with GIP/GLP-1 receptor agonists rests on phase 3 randomised placebo-controlled trials. Below are those findings, each stated with the measured result of the study.

  1. In a 72-week randomised placebo-controlled trial of 2,539 adults, mean body-weight change was −16.0% at 5 mg, −21.4% at 10 mg and −22.5% at 15 mg, against −2.4% on placebo.

    Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine, 2022

  2. Followed to 176 weeks, 1.3% of treated participants with obesity and pre-diabetes progressed to type 2 diabetes against 13.3% on placebo (hazard ratio 0.07, P < 0.001). Mean weight change was −19.7% at 15 mg versus −1.3% on placebo.

    Tirzepatide for Obesity Treatment and Diabetes PreventionNew England Journal of Medicine, 2024

  3. An updated systematic review and meta-analysis pooling the once-weekly tirzepatide trials against placebo, including SURMOUNT-2, confirms the weight-management effect across the pooled population.

    Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: an updated systematic review and meta-analysis including the latest SURMOUNT-2 trialSystematic review and meta-analysis, 2024

These studies describe outcomes observed in their own trial populations. They are not a prediction of your result and are not a guarantee of any treatment outcome. Stem cell therapy at Healthi Life is provided only after a physician consultation and an individual medical assessment.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

This page is for general information and does not constitute medical advice, diagnosis, or treatment. Results vary between individuals. ⁨Mounjaro, Wegovy — tirzepatide, semaglutide⁩ is a prescription medicine, dispensed and administered only after assessment by a licensed physician. This page is medical information, not an advertisement or an offer of treatment. Always consult a qualified physician about your condition. See our full medical disclaimer.

Book a Medical Weight Loss Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and the GLP-1 molecule best suited to your profile.

Location

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

Hours

Mon-Sat: 11:00 AM – 7:00 PM

Response time: Under 2 hours

Book ConsultationWhatsApp Us+66 91 999 1744

Related Services

Explore other treatments that complement your wellness journey

Recovery & Performance

All recovery & performance treatments

Learn more

Peptide Therapy

Physician-led peptide programs

Learn more

Wegovy Bangkok

Semaglutide GLP-1 program

Learn more

Ozempic Bangkok

Semaglutide (Ozempic) GLP-1 care

Learn more

Retatrutide Bangkok

Investigational triple agonist

Learn more

Mounjaro Bangkok

Tirzepatide dual GIP/GLP-1 program

Learn more